ARCHIVES

Top Officials Resign From San Antonio’s Institute for Drug Development.

This article is from The Cancer Letter archive.

Vol. 33 No. 03 | January 26, 2007

Download PDF Visit The Full Archive

Related Articles

Cancer Groups Fear Clinical Trials Coverage Will Not Be Implemented Across Exchanges

July 3, 2013

Memorial’s Scher Warns FDA About Flaws In Provenge Data, Urges Not To Approve.

April 13, 2007

Phase III Nexavar Trial Fails Primary Endpoint

August 29, 2014

Other Institutes Fare Well With ’77 Appropriations

August 20, 1976

Statins May Not Have Impact On Testosterone In The Blood

August 31, 2007

Clearinghouse Asks Short Term Test Use To Help In Chemical Selection

September 17, 1977